Cargando…

Repurposing Anti-Cancer Drugs for COVID-19 Treatment

The novel coronavirus disease 2019 (COVID-19) pandemic has caused catastrophic damage to human life across the globe along with social and financial hardships. According to the Johns Hopkins University Coronavirus Resource Center, more than 41.3 million people worldwide have been infected, and more...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borcherding, Nicholas, Jethava, Yogesh, Vikas, Praveen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680713/ https://www.ncbi.nlm.nih.gov/pubmed/33239864 http://dx.doi.org/10.2147/DDDT.S282252

Ejemplares similares

Drug repurposing for the treatment of COVID-19
por: Kato, Yuri, et al.
Publicado: (2022)

Repurposing Existing Drugs for the Treatment of COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

The clinical promise of immunotherapy in triple-negative breast cancer
por: Vikas, Praveen, et al.
Publicado: (2018)

A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19
por: Banerjee, Surojit, et al.
Publicado: (2023)

An Overview of Repurposed Drugs for Potential COVID-19 Treatment
por: Govender, Kamini, et al.
Publicado: (2022)

A computational drug repurposing approach in identifying the cephalosporin antibiotic and anti-hepatitis C drug derivatives for COVID-19 treatment
por: Kumar, Raj, et al.
Publicado: (2021)

Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
por: Chavda, Vivek P., et al.
Publicado: (2021)

Repurposing drugs for treatment of COVID-19
por: Venkatesan, Priya
Publicado: (2021)

The evidence for repurposing anti-epileptic drugs to target cancer
por: Aroosa, Mir, et al.
Publicado: (2023)

The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19
por: Robinson, Philip C., et al.
Publicado: (2020)

Impact of Liver Functions by Repurposed Drugs for COVID-19 Treatment
por: Zhang, Rongzhi, et al.
Publicado: (2022)

Repurposing anticancer drugs for the management of COVID-19
por: El Bairi, Khalid, et al.
Publicado: (2020)

Drug repurposing approach to fight COVID-19
por: Singh, Thakur Uttam, et al.
Publicado: (2020)

Artificial intelligence in COVID-19 drug repurposing
por: Zhou, Yadi, et al.
Publicado: (2020)

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
por: Costa, Bárbara, et al.
Publicado: (2021)

Brief review on repurposed drugs and vaccines for possible treatment of COVID-19
por: De, Priyasha, et al.
Publicado: (2021)

Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment
por: Taibe, Noha Samir, et al.
Publicado: (2022)

Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
por: Sukhatme, Vidula, et al.
Publicado: (2015)

Repurposed GI Drugs in the Treatment of COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Prospects for repurposing CNS drugs for cancer treatment
por: Abdelaleem, Mohamed, et al.
Publicado: (2019)

Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent
por: Van Nuffel, An MT, et al.
Publicado: (2015)

Drug Repurposing for Prevention and Treatment of COVID-19: A Clinical Landscape
por: Hossain, Md. Shahadat, et al.
Publicado: (2020)

Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches
por: Batalha, Pedro N., et al.
Publicado: (2021)

Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
por: Baburaj, Gayathri, et al.
Publicado: (2021)

COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs
por: Lee, Jong Hoon, et al.
Publicado: (2022)

AI-powered drug repurposing for developing COVID-19 treatments
por: Liu, Zhichao, et al.
Publicado: (2022)

Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review
por: Acharya, Yogesh, et al.
Publicado: (2020)

Drug Repurposing: The Mechanisms and Signaling Pathways of Anti-Cancer Effects of Anesthetics
por: Wu, King-Chuen, et al.
Publicado: (2022)

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment
por: Martinez, Miguel Angel
Publicado: (2021)

Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
por: Martinez, Miguel Angel
Publicado: (2021)

Repurposed Drugs in Gastric Cancer
por: Araújo, Diana, et al.
Publicado: (2022)

Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer
por: Lourenço, Tânia, et al.
Publicado: (2023)

Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug
por: Uckun, Fatih M., et al.
Publicado: (2021)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kibr3rtgtur524a6hukks3fq1m